{"denomUnitsSelected":"Participants","description":"Toxicity will be assessed according to the NCI Common Terminology Criteria for Adverse Events (CTCAE), version 5.0.","reportingStatus":"NOT_POSTED","timeFrame":"From start of study treatment (Dara-Rd) up to 30 days post last dose of study treatment (Dara, R, V or d)","title":"Incidence of Treatment-emergent Adverse Events","type":"SECONDARY"}